LINEAGE CELL THERAPEUTICS IN (LCTX) Stock Earnings & Estimates
USA - NYSEARCA:LCTX - US53566P1093 - Common Stock
1.71 USD
+0.16 (+10.32%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14.7M 238.71% | 8.945M -39.15% | 9.499M 6.19% | 8.808M -7.27% | 24.31M 176.00% | 18.737M -22.92% | 58.77M 213.66% | 90.845M 54.58% | 161.47M 77.74% | 281.6M 74.40% | 407.68M 44.77% | |
| EBITDA YoY % growth | -21.79M 54.92% | -24.041M -10.33% | -20.869M 13.19% | -27.183M -30.26% | -15.555M 42.78% | -26.01M -67.21% | -25.342M 2.57% | -21.471M 15.27% | -16.85M 21.52% | -18.207M -8.05% | -19.737M -8.40% | |
| EBIT YoY % growth | -22.52M 54.24% | -24.733M -9.83% | -21.478M 13.16% | -34.841M -62.22% | -19.131M 45.09% | -26.767M -39.91% | 8.387M 131.33% | 34.77M 314.57% | 123.81M 256.08% | 241.83M 95.32% | 397.25M 64.27% | |
| Operating Margin | -153.20% | -276.50% | -226.11% | -395.56% | -78.70% | -142.86% | 14.27% | 38.27% | 76.68% | 85.88% | 97.44% | |
| EPS YoY % growth | -0.15 42.31% | -0.13 13.33% | -0.10 23.08% | -0.15 -50.08% | -0.07 53.40% | -0.09 -26.40% | 0.05 155.38% | 0.12 141.67% | 0.43 259.91% | 0.73 71.26% | 1.05 44.52% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.03 -31.12% | -0.03 -176.83% | -0.01 74.50% | -0.02 70.86% | -0.03 -16.69% | -0.04 -28.96% | -0.03 -500.00% | -0.03 -50.00% | -0.03 16.67% | -0.04 -14.29% |
| Revenue Q2Q % growth | 2.346M -37.92% | 2.128M -25.80% | 9.305M 519.51% | 5.097M 84.34% | 1.265M -46.08% | 1.265M -40.55% | 1.117M -88.00% | 1.117M -78.09% | 1.117M -11.70% | 1.117M -11.70% |
| EBITDA Q2Q % growth | -5.753M -70.10% | -5.789M -28.60% | -7.048M -11.15% | -7.12M -54.61% | -7.844M -36.35% | -7.925M -36.92% | -7.997M -13.46% | -8.16M -14.61% | -8.16M -4.03% | -8.16M -2.96% |
| EBIT Q2Q % growth | -6.743M -75.59% | -7.324M -43.33% | -456.195K 92.99% | -5.158M -4.42% | -9.728M -44.28% | -10.604M -44.78% | -8.654M -1,796.93% | -8.827M -71.13% | -9M 7.48% | -9.169M 13.54% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.07 -133.33% | -0.03 | -0.04 | -152.86% |
| Q1 2025 Q2Q % growth | -0.02 50.00% | -0.03 | 0.01 | 21.57% |
| Q4 2024 Q2Q % growth | -0.01 66.67% | -0.01 | 0.00 | -14.40% |
| Q3 2024 Q2Q % growth | -0.02 50.00% | -0.04 | 0.02 | 54.25% |
| Q2 2024 Q2Q % growth | -0.03 | -0.05 | 0.02 | 36.06% |
| Q1 2024 Q2Q % growth | -0.04 -33.33% | -0.04 | 0.00 | -2.31% |
| Q4 2023 Q2Q % growth | -0.03 | -0.04 | 0.01 | 31.38% |
| Q3 2023 Q2Q % growth | -0.04 | -0.04 | 0.00 | 8.50% |
| Q2 2023 Q2Q % growth | -0.03 25.00% | -0.05 | 0.02 | 33.59% |
| Q1 2023 Q2Q % growth | -0.03 25.00% | -0.04 | 0.01 | 23.27% |
| Q4 2022 Q2Q % growth | -0.03 82.35% | -0.04 | 0.01 | 20.81% |
| Q3 2022 Q2Q % growth | -0.04 20.00% | -0.04 | 0.00 | -12.04% |
| Q2 2022 Q2Q % growth | -0.04 -33.33% | -0.04 | 0.00 | 8.50% |
| Q1 2022 Q2Q % growth | -0.04 -300.00% | -0.03 | -0.01 | -15.34% |
| Q4 2021 Q2Q % growth | -0.17 -1,800.00% | -0.05 | -0.12 | -257.12% |
| Q3 2021 Q2Q % growth | -0.05 | -0.05 | 0.00 | -2.12% |
| Q2 2021 Q2Q % growth | -0.03 25.00% | -0.04 | 0.01 | 19.79% |
| Q1 2021 Q2Q % growth | -0.01 83.33% | -0.04 | 0.03 | 71.99% |
| Q4 2020 Q2Q % growth | 0.01 133.33% | -0.05 | 0.06 | 121.31% |
| Q3 2020 Q2Q % growth | -0.05 58.33% | -0.05 | 0.00 | -8.93% |
| Q2 2020 Q2Q % growth | -0.04 80.00% | -0.04 | 0.00 | 1.96% |
| Q1 2020 Q2Q % growth | -0.06 -120.00% | -0.05 | -0.01 | -22.55% |
| Q4 2019 Q2Q % growth | -0.03 | -0.05 | 0.02 | 43.44% |
| Q3 2019 Q2Q % growth | -0.12 | -0.05 | -0.07 | -120.60% |
| Q2 2019 Q2Q % growth | -0.20 | -0.05 | -0.15 | -277.07% |
| Q1 2019 Q2Q % growth | 0.30 | -0.06 | 0.36 | 574.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.765M 96.38% | 1.502M | 1.263M | 84.09% |
| Q1 2025 Q2Q % growth | 1.502M 4.02% | 1.904M | -402K | -21.11% |
| Q4 2024 Q2Q % growth | 2.868M 37.36% | 1.654M | 1.214M | 73.40% |
| Q3 2024 Q2Q % growth | 3.779M 203.29% | 1.054M | 2.725M | 258.54% |
| Q2 2024 Q2Q % growth | 1.408M -56.34% | 988.635K | 419.365K | 42.42% |
| Q1 2024 Q2Q % growth | 1.444M -39.48% | 1.387M | 57K | 4.11% |
| Q4 2023 Q2Q % growth | 2.088M 8.75% | 1.336M | 752K | 56.29% |
| Q3 2023 Q2Q % growth | 1.246M -58.47% | 2.646M | -1.4M | -52.91% |
| Q2 2023 Q2Q % growth | 3.225M -29.12% | 2.241M | 984K | 43.91% |
| Q1 2023 Q2Q % growth | 2.386M -54.47% | 2.049M | 337K | 16.45% |
| Q4 2022 Q2Q % growth | 1.92M 64.10% | 2.617M | -697K | -26.63% |
| Q3 2022 Q2Q % growth | 3M 32.16% | 3.975M | -975K | -24.53% |
| Q2 2022 Q2Q % growth | 4.55M 792.16% | 3.758M | 792K | 21.08% |
| Q1 2022 Q2Q % growth | 5.24M 1,243.59% | 7.47M | -2.23M | -29.85% |
| Q4 2021 Q2Q % growth | 1.17M 225.00% | 856.8K | 313.2K | 36.55% |
| Q3 2021 Q2Q % growth | 2.27M 298.25% | 521.22K | 1.749M | 335.52% |
| Q2 2021 Q2Q % growth | 510K 30.77% | 418.2K | 91.8K | 21.95% |
| Q1 2021 Q2Q % growth | 390K -23.53% | 357K | 33K | 9.24% |
| Q4 2020 Q2Q % growth | 360K -70.97% | 939.93K | -579.93K | -61.70% |
| Q3 2020 Q2Q % growth | 570K | 438.6K | 131.4K | 29.96% |
| Q2 2020 Q2Q % growth | 390K -50.00% | 568.905K | -178.905K | -31.45% |
| Q1 2020 Q2Q % growth | 510K -45.16% | 656.88K | -146.88K | -22.36% |
| Q4 2019 Q2Q % growth | 1.24M | 1.051M | 189K | 17.98% |
| Q3 2019 Q2Q % growth | 570K | 824.497K | -254.497K | -30.87% |
| Q2 2019 Q2Q % growth | 780K | 1.008M | -228K | -22.62% |
| Q1 2019 Q2Q % growth | 930K | 760.512K | 169.488K | 22.29% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 5.27% | 29.89% | 0% | -66.58% |
| Revenue | -2.86% | 69.14% | 1.25% | 6.61% |